Event Detail
IND Submission for a 505(b)(2) Product
October 3, 2012 - san francisco CA US
Online Compliance Panel
onlinecompliancepanel1@gmail.com
Phone: +1-510-857-5896
Fax: +1-510-509-9659
A 505(b)2) product is an improved or altered version or a new use application for a previously FDA-approved drug. This unique regulatory pathway, available only for marketing approval in the US, offers an attractive pathway to cheaper and faster new drug development, particularly to a manufacturer with experience in developing generic products. However, 505(b)(2) products require evidence from clinical trials conducted under an IND in support of the marketing approval application.